NR3C1 and breast carcinoma: This may also be due to intratumoral heterogeneity but in breast cancer patients, steroid hormone receptor profiles were also reported to be different between pre- and post-chemotherapy [34], and similar changes in GR may occur in ESCC patients but further investigations are required for clarification.